Skip to main content

Solutions for professionals

Together, we are addressing health holistically

2024 Annual Health Care Trends Report

Get expert analysis for C-suite health care leaders on the forces driving change.

Insights

Browse insights on making the health system work better for all

Making health screenings more convenient

The pandemic has changed how people get care. At-home kits meet people where they live.

Webinar on demand

Realizing the full potential of clinicogenomics

Length: 50 minutes

 

Video Player is loading.
Duration -:-
Current Time 0:00
Loaded: 0%
Remaining Time -:-

    Paving the way for new health discoveries

    Hailed as the next frontier in drug discovery and development, genomics has, in many ways, fallen short. One reason is the lack of existing datasets combining high-quality genomic sequencing information and rich, longitudinal phenotypic information.

    During this Endpoints News webinar, industry experts discuss the progress made in clinicogenomics, the development of these datasets and their application in health care, drug discovery and development.

    Learn more about Optum Life Sciences here

    FEATURED SPEAKERS:

    Dr. Ashley Brenton, VP, Real-World Evidence and Genomics, Life Sciences, Optum

     

    Dr. Michael Hultner, VP, Head of Genomics Strategy, Optum Arsalan Arif, Founder and Publisher, Endpoints News (moderator)

    Related resources

    Clinicogenomics: The next big leap in real-world data

    Optum clinical genomics is positioned to shape a new generation of evidence that accelerates understanding of disease.

    Clinicogenomics: new, linked data is advancing research

    Rich, longitudinal clinicogenomics data can fuel all stages of drug development.

    Clinicogenomics Enable Precision Drug Development | Optum